Physician profile
Vanessa Vanstee
NPI 1528094372
$18,638.46
in general payments reported to CMS, 2019-2025
32 companies · $7,567 in 2025
The $7,567 reported for 2025 was more than what 86% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $1,569 · 2021: $1,697 · 2022: $1,704 · 2023: $2,138 · 2024: $2,421 · 2025: $7,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,389 · Consulting Fee: $4,125 · Travel and Lodging: $1,496 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,389.15 |
| Consulting Fee | $4,125.00 |
| Travel and Lodging | $1,495.96 |
| Education | $115.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $6,787.83 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,768.63 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Pfizer INC. | $1,405.92 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,061.50 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $1,001.99 | 2019-2025 | Dupixent |
| Genzyme Corporation | $783.29 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $642.64 | 2020-2025 | Cuvitru, Hyqvia, Takhzyro |
| Csl Behring | $608.04 | 2019-2025 | Hizentra, Haegarda |
| Pharming Healthcare, INC. | $606.72 | 2019-2025 | Ruconest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.59 | 2019-2023 | Spiriva Respimat |
| Amgen INC. | $460.33 | 2022-2025 | Tezspire |
| Abbvie INC. | $353.86 | 2021-2023 | Rinvoq |
| Biocryst US Sales Co., LLC | $216.00 | 2023-2024 | Orladeyo |
| Teva Pharmaceuticals USA, INC. | $215.90 | 2019-2021 | |
| Grifols USA, LLC | $190.36 | 2019-2025 | Xembify |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $140.55 | 2024-2025 | Ebglyss |
| Gc Biopharma USA, INC. | $133.55 | 2025 | Alyglo |
| Octapharma USA, INC. | $131.57 | 2019-2020 | |
| Leo Pharma INC. | $128.85 | 2022-2025 | Adbry |
| Alk-Abello, INC | $90.20 | 2019-2021 | |
| Kaleo, INC. | $65.60 | 2022-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $65.37 | 2021 | |
| Blueprint Medicines Corporation | $62.50 | 2022-2023 | Ayvakit |
| Organon LLC | $52.94 | 2025 | |
| Horizon Therapeutics Plc | $45.04 | 2021-2022 | |
| Genentech USA, INC. | $36.45 | 2019-2020 | |
| Optinose US, INC. | $28.10 | 2021 | |
| Covis Pharma Gmbh | $23.04 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $20.52 | 2025 | Neffy |
| Aimmune Therapeutics, INC. | $17.99 | 2021 | |
| Allergan, INC. | $16.65 | 2021 | |
| Bio Products Laboratory USA, INC. | $11.94 | 2023 | Coagadex, Gammaplex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Vanstee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.